Skip to main content
  • En
  • Français

Top Navigation

  • Newsroom
  • Contact Us

Main navigation

  • About Us
  • Products
  • Clinical Studies
  • Investors
  • Obligations convertibles
    • Documents liés à l'émission et à la conversion d'obligations convertibles
    • Nouveau dénominateur en date du 28 avril 2026
    • Nouveau dénominateur en date du 08 mai 2025
  • News
  • En
  • Français

English version is not updated since 2025-01-01.

Bond information

Documents liés à l'émission et à la conversion d'obligations convertibles

  • Read more about Documents liés à l'émission et à la conversion d'obligations convertibles

Rapports spéciaux du Conseil d'administration

Notification de transparence

Security Notes

Summary of the conversion terms offered

  • Read more about Summary of the conversion terms offered

Convertible bonds

  • Read more about Convertible bonds

Press Release - Regulated Information

Private Placement

  • Read more about Private Placement

Private investment in public equity (PIPE)

  • Read more about Private investment in public equity (PIPE)

Press releases and documentation

Convertible bonds

  • Read more about Convertible bonds

Convertible bonds

  • Read more about Convertible bonds

Private Placement

  • Read more about Private Placement

Press releases and documentation

Convertible bonds

  • Read more about Convertible bonds

Bone Therapeutics announces half-year results for 2018

  • Read more about Bone Therapeutics announces half-year results for 2018

Pagination

  • Next page ››
Subscribe to Bond information
Wallonie Eu Flag

BioSenic SA
Avenue Léon champagne, 3
1480 Saintes – Belgium
info@biosenic.com
 

Sign upfor our press releases

Receive information about BioSenic

Sign Up

Footer menu

  • Privacy Policy
  • Trademarks Copyrights
  • Users conditions